KRM Ayurveda Limited is bringing traditional wellness to the stock market with a ₹77.49 crore IPO. As the company scales its hospital network and telemedicine platform, we analyze if its 50% RoE and double-digit grey market premium make it a 'Subscribe' for your 2026 portfolio

Shadowfax Technologies is hitting the markets with a ₹1,907 crore IPO. As the company transitions from a high-burn startup to a profitable logistics powerhouse, we analyze if its asset-light model and 23% market share justify the premium valuation. Read our full breakdown of the GMP and subscription strategy

Explore the Anthem Biosciences IPO! Get detailed information on this leading CRDMO, including key dates, strong financials, current Grey Market Premium (GMP), and our "Subscribe" recommendation for long-term investors.